
Cardiolink
科睿驰医疗
Cardiolink
Biotech/Healthcare
Keruichi (Keruichi Medical) was founded at the end of 2015 and is a platform company focused on the R&D, manufacturing, sales, and service of vascular interventional medical devices. Headquartered in Shenzhen, it has two distinctive technology platforms and GMP-certified Class 10,000 cleanroom…
Latest round: Series D (2021)
Source: ChinaBulls — chinabulls.com
Last updated 2021-12-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.